Risk of secondary progressive multiple sclerosis: A longitudinal study.
Adam FambiatosVilija JokubaitisDana HorakovaEva Kubala HavrdovaMaria TrojanoAlexandre PratMarc GirardPierre DuquetteAlessandra LugaresiGuillermo IzquierdoFrancois Grand'MaisonPierre GrammondPatrizia SolaDiana FerraroRaed AlroughaniMurat TerziRaymond HuppertsCavit BozJeannette Lechner-ScottEugenio PucciRoberto BergamaschiVincent Van PeschSerkan OzakbasFranco GranellaRecai TurkogluGerardo IulianoDaniele SpitaleriPamela McCombeClaudio SolaroMark SleeRadek AmpapaAysun SoysalThor PetersenJose Luis Sanchez-MenoyoFreek VerheulJulie PrevostYoussef SidhomBart Van WijmeerschSteve VucicEdgardo CristianoMaria Laura SaladinoNorma DeriMichael BarnettJavier OlascoagaFraser MooreOlga SkibinaOrla GrayYara Dadalti FragosoBassem YamoutCameron ShawBhim SinghalNeil ShueySuzanne HodgkinsonAyse AltintasTalal Al-HarbiTunde CsepanyBruce TaylorJordana HughesJae-Kwan JunAnneke Van Der WaltTim SpelmanHelmut ButzkuevenTomas KalincikPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2019)
Risk of secondary progressive multiple sclerosis increases with age, duration of illness and worsening disability and decreases with improving disability. Therapy may delay the onset of secondary progression.